Drug Type CAR-T |
Synonyms AntiCD19 CART cell therapy BiocurePharm |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia | IND Application | South Korea | 30 Dec 2020 | |
| Acute Lymphoblastic Leukemia | IND Application | South Korea | 30 Dec 2020 |





